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Urinary tract infections (UTI) are the most common nosoco-
mial infections in both acute-care hospitals and long-term-care
facilities. Results of various European national prevalence
studies show that they account for 23–49% of all nosocomial
infections [1]. The costs of prevention, detection and treatment
of UTIs significantly affect a country’s health-care budget so
that even a small decrease in the UTI rate would have important
economic implications.
However, information about the epidemiology of UTI, as
well as studies investigating the best practice for prevention,
detection and treatment of these infections is still quite limited.
A MEDLINE scan of the last 10 years, with the search term
‘nosocomial urinary tract infection’, produced only 279 articles,
whereas the terms ‘nosocomial pneumonia’ or ‘nosocomial
sepsis’ produced 1092 and 788 articles, respectively.
This issue of Clinical Microbiology and Infection includes three
articles that highlight different aspects of the problem of noso-
comial UTIs in European countries. Two articles report the
results of a study undertaken by the European Study Group on
Nosocomial Infections (ESGNI) [2,3].
The first article discusses microbiology workload, etiology
and antimicrobial susceptibility. According to the information
obtained in a questionnaire from 228 hospitals in 29 European
countries, the number of urine samples obtained for culturing
was 324 per 1000 admissions in 1999. However, the cut-off
values of colony-forming units (CFU) used for evaluating a
urine sample as ‘potentially significant’ varied from institution
to institution. A point prevalence design was also used to
describe the situation on the study day in February 2000 from
the perspective of the microbiology laboratory: 5152 urine
samples were analysed, 18.5% being positive (>105 CFU/mL).
The micro-organisms isolated from significant nosocomially
acquired bacteriuria episodes and the antibiotic susceptibility
profiles are presented regardless of the laboratory methods used.
For the most frequent pathogen, Escherichia coli (35.6%), 54.8%
of isolates were resistant to ampicillin, 28% to cotrimoxazole
and 9% to ciprofloxacin.
The second article reports on the incidence, clinical
characteristics and outcome of nosocomial UTIs. One hundred
and forty-one hospitals from 25 European countries partici-
pated; data from 298 episodes were analysed and evaluated with
regard to the use of catheters, underlying diseases and adequacy
of treatment. Furthermore, information concerning institu-
tional bladder catheter guidelines was recorded. It was found
that 62.8% of nosocomial UTIs were catheter associated. A
closed drainage system was used in only 78.5% of catheterized
patients, and a silver-coated catheter in 2.2%. Of the infected
patients, 75.5% received antibiotics over 7-day periods, on
average.
The third article presents results from a microbiology labora-
tory in Norway [4]. Data on etiology and susceptibility of UTI
with patients in and outside hospitals and nursing homes are
given for a period of 34 months (1997–99). A total of 52 350
samples were analysed retrospectively. Escherichia coli was the
most frequent organism found in hospitals (56.7%), but only
24.5% were resistant to ampicillin and 18% to trimethoprim/
sulfamethoxazole (TMX). Quinolones were not tested, because
they are not recommended for use in Norway.
These three reports illustrate a number of important points
regarding nosocomial UTIs. The first is that such infections are
probably more common than most health-care workers realize.
We need more data about the actual presence of UTIs and their
trends.
As early as 1980, 20 years ago, a European multicenter
prevalence survey of UTIs was carried out [5]. This study of
3899 medical patients in 169 wards was performed simulta-
neously in eight countries in northern Europe, including
England, the Netherlands, Germany and Austria. A point
prevalence of nosocomial UTIs of 6.5% was noted.
It is difficult, however, to describe the situation accurately
and to compare properly the infection rates found in different
studies. The definition of nosocomial UTI varies between
hospitals and countries, as is apparent from the ESGNI study.
Prospective studies for establishing a specific quantitative level
to indicate infection have not yet been carried out. Therefore, a
consensus throughout Europe for the interpretation of urine
cultures is urgently required.
The same is true of the indication for urine cultures. On the
one hand, the majority of catheter-associated infections are
missed and symptomatic infections are detected, if culturing is
performed, only when symptoms for UTI are already available.
In particular, catheter-associated UTI are rarely symptomatic,
more than 90% being asymptomatic [6]. Thus, routine screen-
ing is necessary in order to acquire accurate epidemiological
data for UTI.
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Most clinicians do not recommend treatment of asympto-
matic bacteriuria in catheterized patients unless the patient is at
high risk due to complications, such as bacteraemia or renal
infection. For most patients with temporary catheters this
condition is transient and resolves itself spontaneously without
any clinical complications. Routine culturing for bacteria in the
urine of catheterized patients, in order to identify asymptomatic
bacteriuria, is therefore not recommended, even at the time of
catheter removal [7].
An overview of the most frequent organisms, including their
resistance situation, is required for the treatment of complicated
UTIs. Asymptomatic catheter-associated bacteriuria especially
is responsible for creating a huge reservoir of antibiotic-resistant
organisms in the hospital setting, particularly in intensive care
units. Transmission of these organisms has been demonstrated
by molecular typing investigations [8]. While the resistance of
those micro-organisms causing UTI was not mentioned at all in
the European study published by Jepsen et al. in 1982 [5], the
problem is now recognized to be a high priority, and the
resistance patterns of UTI pathogens are a serious cause for
concern, particularly in southern and eastern Europe. A certain
number of urine cultures should, therefore, be undertaken to
guarantee sufficient information about the susceptibility of UTI
pathogens.
Clear guidelines for the implementation of a consistent
program with respect to urine cultures would clearly be helpful
to most clinicians [9].
Some questions concerning the prevention of UTIs remain
unresolved. The single most effective preventive measure is
probably to avoid the use of indwelling catheters whenever
possible. Jain et al. found, in a North American hospital, that the
placement of urinary catheters was unjustified in 21% of cases,
and that continued catheterization was unjustified in 47% [10].
Similar results for Europe have been found in the study pre-
sented in this issue. Unfortunately, the criteria for considering
catheterization unjustified, and assessment of the need for
continued catheter use are not described in detail.
The last significant advance in the prevention of catheter-
related UTI, i.e. the implementation of closed drainage systems,
took place in the 1960s. It is therefore astonishing that in this
European study, in the year 2000, more than 20% of catheter-
ized patients were being treated without the benefit of a closed
drainage system. On the other hand, 2.2% of the patients did
have a silver-coated catheter. The silver alloy, hydrogel-coated
latex catheter would appear to prevent UTI and may be worth
the extra cost [11], but further investigations are needed to
establish a definite advantage.
I am certain that the three reports presented in this issue will
stimulate further activity toward establishing current and evi-
dence-based guidelines for preventing, diagnosing and treating
nosocomial UTIs.
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